View Financial HealthNextFerm Technologies 배당 및 자사주 매입배당 기준 점검 0/6NextFerm Technologies 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-13.6%자사주 매입 수익률총 주주 수익률-13.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.공시 • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, IsraelBoard Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).Reported Earnings • Apr 02Full year 2024 earnings released: US$0.90 loss per share (vs US$0.94 loss in FY 2023)Full year 2024 results: US$0.90 loss per share. Net loss: US$5.32m (loss widened 25% from FY 2023).New Risk • Mar 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 2.4% per year over the past 5 years. Revenue is less than US$1m (US$110k revenue). Market cap is less than US$10m (₪12.2m market cap, or US$3.39m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding).New Risk • May 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.7m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 10% per year over the past 5 years. Revenue is less than US$1m (US$283k revenue). Market cap is less than US$10m (₪27.8m market cap, or US$7.57m). Minor Risk Shareholders have been diluted in the past year (5.8% increase in shares outstanding).Reported Earnings • Apr 01Full year 2023 earnings released: US$0.06 loss per share (vs US$0.54 loss in FY 2022)Full year 2023 results: US$0.06 loss per share (improved from US$0.54 loss in FY 2022). Net loss: US$4.25m (loss narrowed 47% from FY 2022).New Risk • Mar 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.2m free cash flow). Earnings have declined by 16% per year over the past 5 years. Revenue is less than US$1m (US$384k revenue). Market cap is less than US$10m (₪20.9m market cap, or US$5.82m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.6% average weekly change).Reported Earnings • Aug 22First half 2023 earnings released: US$0.04 loss per share (vs US$0.23 loss in 1H 2022)First half 2023 results: US$0.04 loss per share (improved from US$0.23 loss in 1H 2022). Net loss: US$2.29m (loss narrowed 34% from 1H 2022).Reported Earnings • Mar 26Full year 2022 earnings released: US$0.54 loss per share (vs US$0.49 loss in FY 2021)Full year 2022 results: US$0.54 loss per share (further deteriorated from US$0.49 loss in FY 2021). Net loss: US$8.07m (loss widened 47% from FY 2021).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.분석 기사 • May 19We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$0.49 (up from US$1.87 loss in FY 2020). Net loss: US$5.51m (loss widened 37% from FY 2020). Revenue was in line with analyst estimates.분석 기사 • Jan 02Here's Why We're Watching NextFerm Technologies' (TLV:NXFR) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...공시 • Jul 15NextFerm Technologies Ltd Obtains Regulatory Approval to Market Astaferm Astaxanthin Antioxidant in CanadaNextFerm Technologies Ltd. announced that Health Canada has granted a regulatory marketing approval for Astaferm(R), its innovative fermented astaxanthin antioxidant in the form of Gummies. This is the only fermented astaxanthin with no odor and flavor. Along with the receipt of Astaferm(R)'s license approval (NPN - Natural Product Number), the company is preparing for the launch of several applications of Astaferm(R) in North America, including for Immunity support, which is a growing segment due to the Covid-19 pandemic. The Company has already supplied initial quantities of Astaferm(R) in Canada and is currently in dialogues with potential customers. Astaferm(R) has a US Self GRAS regulatory approval and was launched in the US at the end of 2020. The product is in early stages of sales, by well-known US dietary supplement brands, such as Carlson Labs and Purity Products. Since Astaferm(R) is flavorless and odorless, the Gummies application constitutes a significant differentiation from other astaxanthin products available on the market, produced from algae with fishy odor, and therefore applied mainly in soft-gels. NextFerm currently prepares to expand the marketing of Astaferm(R) for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages, and fermented Astaferm(R) oil for soft-gels with competitive pricing.분석 기사 • Jul 08We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 NXFR.M 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: NXFR.M 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장NextFerm Technologies 배당 수익률 vs 시장NXFR.M의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (NXFR.M)n/a시장 하위 25% (IL)1.8%시장 상위 25% (IL)5.5%업계 평균 (Chemicals)1.5%분석가 예측 (NXFR.M) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 NXFR.M 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 NXFR.M 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 NXFR.M 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: NXFR.M 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIL 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 19:30종가2026/05/12 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스NextFerm Technologies Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).
New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.
공시 • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, Israel
Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).
Reported Earnings • Apr 02Full year 2024 earnings released: US$0.90 loss per share (vs US$0.94 loss in FY 2023)Full year 2024 results: US$0.90 loss per share. Net loss: US$5.32m (loss widened 25% from FY 2023).
New Risk • Mar 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 2.4% per year over the past 5 years. Revenue is less than US$1m (US$110k revenue). Market cap is less than US$10m (₪12.2m market cap, or US$3.39m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding).
New Risk • May 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.7m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 10% per year over the past 5 years. Revenue is less than US$1m (US$283k revenue). Market cap is less than US$10m (₪27.8m market cap, or US$7.57m). Minor Risk Shareholders have been diluted in the past year (5.8% increase in shares outstanding).
Reported Earnings • Apr 01Full year 2023 earnings released: US$0.06 loss per share (vs US$0.54 loss in FY 2022)Full year 2023 results: US$0.06 loss per share (improved from US$0.54 loss in FY 2022). Net loss: US$4.25m (loss narrowed 47% from FY 2022).
New Risk • Mar 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.2m free cash flow). Earnings have declined by 16% per year over the past 5 years. Revenue is less than US$1m (US$384k revenue). Market cap is less than US$10m (₪20.9m market cap, or US$5.82m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.6% average weekly change).
Reported Earnings • Aug 22First half 2023 earnings released: US$0.04 loss per share (vs US$0.23 loss in 1H 2022)First half 2023 results: US$0.04 loss per share (improved from US$0.23 loss in 1H 2022). Net loss: US$2.29m (loss narrowed 34% from 1H 2022).
Reported Earnings • Mar 26Full year 2022 earnings released: US$0.54 loss per share (vs US$0.49 loss in FY 2021)Full year 2022 results: US$0.54 loss per share (further deteriorated from US$0.49 loss in FY 2021). Net loss: US$8.07m (loss widened 47% from FY 2021).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
분석 기사 • May 19We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$0.49 (up from US$1.87 loss in FY 2020). Net loss: US$5.51m (loss widened 37% from FY 2020). Revenue was in line with analyst estimates.
분석 기사 • Jan 02Here's Why We're Watching NextFerm Technologies' (TLV:NXFR) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
공시 • Jul 15NextFerm Technologies Ltd Obtains Regulatory Approval to Market Astaferm Astaxanthin Antioxidant in CanadaNextFerm Technologies Ltd. announced that Health Canada has granted a regulatory marketing approval for Astaferm(R), its innovative fermented astaxanthin antioxidant in the form of Gummies. This is the only fermented astaxanthin with no odor and flavor. Along with the receipt of Astaferm(R)'s license approval (NPN - Natural Product Number), the company is preparing for the launch of several applications of Astaferm(R) in North America, including for Immunity support, which is a growing segment due to the Covid-19 pandemic. The Company has already supplied initial quantities of Astaferm(R) in Canada and is currently in dialogues with potential customers. Astaferm(R) has a US Self GRAS regulatory approval and was launched in the US at the end of 2020. The product is in early stages of sales, by well-known US dietary supplement brands, such as Carlson Labs and Purity Products. Since Astaferm(R) is flavorless and odorless, the Gummies application constitutes a significant differentiation from other astaxanthin products available on the market, produced from algae with fishy odor, and therefore applied mainly in soft-gels. NextFerm currently prepares to expand the marketing of Astaferm(R) for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages, and fermented Astaferm(R) oil for soft-gels with competitive pricing.
분석 기사 • Jul 08We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...